Innovent Starts US Trial of “Pivotal” CD47 Immunotherapy

Life Science

Abbisko Completes $42 Million Series B Funding for Oncology Candidates

Life Science

The “Cambrian Explosion” of Innovative Drugs in China Biopharma: Five Themes

Life Science

Celgene Pays Exscientia $25 Million up Front for 3-Year AI Research Deal

Life Science

WuXi STA forms Strategic Partnership with Beta Pharma

Life Science

Xiangxue Approved to Start China Trial of T-Cell Therapy for Solid Tumors

Life Science

WuXi Biologics Receives EMA GMP Certificates

Life Science

AgraFlora Organics Increases Ownership Position in Propagation Services Canada Inc.

Cannabis, Life Science

Cellular Biomedicine Group Announces Proposed Follow-on Offering of Common Stock

Life Science

BGI’s GenoImmune Raises $18 Million for Neoantigen Discovery Services

Life Science

Tianjin’s CanSino to Raise $160.5 Million for Novel Vaccines in Hong Kong IPO

Life Science

Grassroots Cannabis Announces Closing of US $90M Capital Raise

Cannabis, Life Science

Canada to create national drug agency to help cut cost of medicines

Life Science

I-Mab Biopharma Announces Dosing of First Subject in Phase 1 Clinical Trial of Anti-GM-CSF Monoclonal Antibody TJM2 in the United States

Life Science

Merck Signs MOU with GenScript for China Plasmid and Viral Vector Manufacturing

Life Science